Stay updated on Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This appears to be a metadata/version label change and does not modify the page's study content or layout.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.2 was applied, replacing v3.4.1; this appears to be a minor version update with no changes to the study data or navigation, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded Revision: v3.4.1. Deleted Revision: v3.4.0.SummaryDifference0.0%

- Check52 days agoChange DetectedUI label updates include Show glossary and Hide glossary, along with wording changes to metadata like 'Last Update Submitted that Met QC Criteria' and 'Last Update Posted'. The revision is listed as v3.4.0, replacing v3.3.4.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this appears to be a minor version bump with no visible changes to the page content.SummaryDifference0.0%

- Check89 days agoChange DetectedExpanded the list of study locations across multiple countries and regions, broadening recruitment options. Removed the HHS Vulnerability Disclosure link and several location subsections.SummaryDifference2%

Stay in the know with updates to Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.